Market revenue in 2023 | USD 90.3 million |
Market revenue in 2030 | USD 198.0 million |
Growth rate | 11.9% (CAGR from 2023 to 2030) |
Largest segment | Disposable equipment |
Fastest growing segment | Disposable Equipment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable Equipment, Capital Equipment, Reusable Equipment |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Stryker Corp, Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, AngioDynamics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiofrequency ablation devices market will help companies and investors design strategic landscapes.
Disposable equipment was the largest segment with a revenue share of 42.75% in 2023. Horizon Databook has segmented the Spain radiofrequency ablation devices market based on disposable equipment, capital equipment, reusable equipment covering the revenue growth of each sub-segment from 2018 to 2030.
In Spain, the number of deaths due to cancer is high and cervical cancer is the second most common cancer in women aged 15 to 44 years. According to HPV Information Center, annually, 2,511 women are diagnosed with cervical cancer and 848 die from the disease in Spain.
Around 20.17 million women above the age of 15 were at a risk of developing cervical cancer. According to Spanish Society of Cardiology, in 2013, the prevalence of AF in those over 40 years was more than 4.4%, and an estimated 1 million patients were suffering from AF, of which more than 90,000 were undiagnosed.
Therefore, increasing incidence of cancer and cardiovascular diseases, rising healthcare expenditure, and increasing awareness about early diagnosis & treatment is expected to propel market growth. According to OECD health statistics, in 2015, Spanish healthcare spending was 9.2% of the GDP with per capita expenditure of USD 2,711.58, in which 71% was public and 29% was private.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain radiofrequency ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into Spain radiofrequency ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account